A Non-coding RNA molecules in multiple myeloma
9.30-10.30 Alberto Rocci (Manchester) - The opportunities and the challenges of microRNA in multiple myeloma
10.30 - 10.50 Luca Agnelli (Milan) - Non-coding RNA: new insights in the multiple myeloma transcriptional landscape
10.50-11.10 Domenica Ronchetti (Milan) - LncRNA in multiple myeloma: an overview
11.10-11.30 Jana Gregorova (Brno) - MicroRNA in extramedullary relapse of multiple myeloma
11.30-12.45 Lunch
B Waldenstrom macroglobulinemia
12.45 – 13.15 Daniela Drandi (Torino) - A bird's eye view of WM
13.15- 13.35 Markéta Stejskalová (Brno) - Detection of clonal WM subpopulations by immunophenotyping
13.35 -14.00 Matouš Hrdinka (Ostrava) - Non-degradative ubiquitination as a new therapeutic target in MyD88 dependent lymphomas?
14.00-14.30 Coffee break
C Hot topics
14.30-15.00 Eva Kriegova (Olomouc) - Serum protein fingerprints associated with MGUS and MM and their changes in MM after autologous stem cell transplantation
15.00-15.30 Petr Vanhara (Brno)- Rapid discrimination of multiple myeloma patients by artificial intelligence coupled with mass spectrometry of peripheral blood plasma
15.30-16.00 Alexander Vdovin (Ostrava) - Deubiquitinase OTUD1 as a new player in pathogenesis of multiple myeloma
16.00-16.30 Martina Zatopkova (Ostrava) - Minimal residual disease in multiple myeloma from genomics point of view
16.30-17.00 – David Vrabel (Brno) - Cell-free DNA – will it be a good marker for multiple myeloma?
7. 9. 2018
